Dear readers of ADxS.org, please forgive the disruption.

ADxS.org needs about $53200 in 2024. In 2023 we received donations from third parties of about $ 32200. Unfortunately, 99.8% of our readers do not donate. If everyone who reads this request makes a small contribution, our fundraising campaign for 2024 would be over after a few days. This donation request is displayed 19,000 times a week, but only 40 people donate. If you find ADxS.org useful, please take a minute and support ADxS.org with your donation. Thank you!

Since 01.06.2021 ADxS.org is supported by the non-profit ADxS e.V..

$3391 of $53200 - as of 2024-02-01
6%
Header Image
Immune reactions and inflammation in other mental disorders

Sitemap

Immune reactions and inflammation in other mental disorders

There is evidence that various mental disorders can also be triggered by viruses or by the immune response to viruses. This is probably neither the only nor the most common cause of mental symptoms, but should be considered as a possible cause.

Certain inflammatory values in the blood are elevated in depression, while other inflammatory values are altered in fatigue and schizophrenia. Stress shows a positive correlation between cortisol and IL-6 in depressed people, whereas in healthy people there is a positive correlation between ACTH and CRP. COX-2 inhibitors and TNFantagonists can be used to treat depression.
Fatigue shows a reduction in IL-6 and TNF-alpha under stress.
A mild chronic inflammation of the brain is suspected in schizophrenia. Autoimmune diseases increase the risk of schizophrenia. Neurotrophic infections in childhood and adolescence can increase the risk of later psychosis. Sleep fragmentation can lead to inflammatory reactions in body tissue that are regulated by the autonomic nervous system.

1. Depression

1.1. Basal blood levels of cytokines

Compared to healthy people, the basal blood values of severely depressed people are on average (i.e. not for everyone affected)

  • Significantly increased:
    • IL-6 (16 studies, n = 892)1 (31 studies).2 Similarly, a recent single study in relation to subclinical depression symptoms found that basal IL-6, but not TNF-α blood levels correlated with the degree of acute (subclinical) depressive mood in remitted depressives as in healthy individuals3
      • Deviating: IL-6 and sIL-6R (following administration of interferon-alpha) did not correlate with increased depression levels after the MADRS. Changes in daily IL-6 levels had no effect on behavior.4
    • CRP (20 studies)2
  • Tends to increase, large fluctuation in results:
    • TNF
      • Increased (meta-analysis of 13 studies, n = 788)1
      • Increase doubtful due to the high heterogeneity and inconsistency of the subgroups2
      • No increase in a recent study in relation to subclinical depression symptoms3
      • The basal IL-6, but not the TNF-α blood levels correlated with the degree of acute (subclinical) depressive mood in remitted depressives as in healthy individuals.3
  • Without differences:
    • IFN-γ (4 studies)1
    • IL-1β (9 studies)12
    • IL-2 (5 studies)1
    • Il-4 (5 studies)1
    • IL-8 (4 studies)1
    • IL-10 (6 studies),1 also a more recent study on subclinical depression symptoms.3

1.2. Stress responses of cytokines in depression

In acutely depressed people (unlike healthy people), there was a positive correlation between the stress responses of cortisol and IL-6 and between the stress responses of adrenaline, TNF-α and CRP. Healthy individuals only showed a significant correlation between ACTH and CRP stress responses.5
In contrast, no correlation was found between the stress responses of cortisol on the one hand and cytokines on the other (IL-6, TNF-α, IL-10) in both non-depressed and remitted (healthy former) depressives.3

1.3. Individual treatment options for depression from an immunological perspective

In depression, a correlation is observed between increased IL-6 levels and the resulting reduction in serotonin synthesis. Furthermore, increased levels of lymphocytes, phagocytes, IL-1, IL-2, INF-α, INF-γ, TNF-α, positive acute-phase proteins, CRP and peripheral mononuclear cells as well as reduced levels of negative acute-phase proteins have been described. Initial studies also indicate an antidepressant effect of (augmentative) COX2 inhibitors in depression, which inhibit IL-1 and IL-6 and increase serotonin levels, among other things. Diclofenac is a COX2 inhibitor, which explains the high cardiovascular risk of diclofenac,6 while ibuprofen and naproxen inhibit COX1 more strongly than COX2.
TNFantagonists also appear to have an antidepressant effect. In addition, the levels of pro-inflammatory inflammatory markers decrease in conventionally successfully treated patients (e.g. with electroconvulsive therapy).7

One study reported that elevated IL-1-α levels were inhibited by supplementation of EPA or DHA, while elevated IL-6 and TNF-α levels were reduced by EPA (only).8

2. Fatigue

In fatigue, a reduction in IL-6 and TNF-alpha was found in response to stress, while healthy people showed an increase as a stress response. In fatigue, ACTH and salivary cortisol levels were also lower overall, while blood cortisol was only basally lower. This showed a negative correlation of the IL-6 and TNF-alpha stress response to the cortisol stress response in fatigue, compared to a positive correlation in healthy individuals.9

3. Schizophrenia

In treatment-resistant schizophrenia, mild chronic encephalitis (inflammation of the brain) is considered.10 Indications for this are

  • Activated monocytes
  • Proteome changes in the blood
  • Discrete cerebrospinal fluid pathologies in more than 60% of treatment-resistant schizophrenic psychoses
  • Activated microglia
  • Disconnectivity in imaging processes.

The detection of low-grade chronic inflammatory factors is a major problem.

For schizophrenia, benefits of augmentative treatment with type 1 cytokine-promoting and COX-2 inhibiting drugs have been described.7

4. Psychosis

A large cohort study of almost 1.2 million children found slight indications that neurotrophic infections in childhood and adolescence are a risk factor for later psychosis:11

  • CMV infections (cytomegalovirus, a herpes virus) almost doubled the risk
  • Mumps virus infections increased the risk
  • Bacterial infections or urban living increased the risk very slightly
  • Enteroviruses did not increase the risk (risk ratio 1.0).

In contrast, psychosis in one parent increased the risk more than 6-fold.

Autoimmune diseases increase the risk of later schizophrenia by 45%. Conversely, 9 autoimmune diseases are more common in schizophrenia sufferers than in non-affected people and 12 autoimmune diseases are more common in parents of schizophrenia sufferers than in parents of non-affected people.12 Another study also comes to the conclusion that autoimmune diseases increase the risk of schizophrenia.13

5. Sleep problems

Both single and chronic sleep fragmentation increased the mRNA and protein levels of cytokines in the body tissue of mice. Changes in inflammatory responses reflected the activation of stress axes with increased corticosterone and noradrenaline. Treatment with 6-OHDA significantly reduced inflammation caused by sleep fragmentation. This indicates a regulation of sleep fragmentation-induced inflammation in body tissue by the autonomic nervous system (sympathetic/parasympathetic nervous system).
Chronic sleep fragmentation showed more severe consequences than single (acute) sleep fragmentation. A one-week recovery from sleep fragmentation sufficiently alleviated the peripheral inflammatory responses, but not the noradrenergic responses.14


  1. Dowlati, Herrmann, Swardfager, Liu, Sham, Reim, Lanctôt (2010): A Meta-Analysis of Cytokines in Major Depression, Biological Psychiatry, Volume 67, Issue 5, 2010, Pages 446-457, ISSN 0006-3223, https://doi.org/10.1016/j.biopsych.2009.09.033.

  2. Haapakoski, Mathieu, Ebmeier, Alenius, Kivimäki (2015): Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder, Brain, Behavior, and Immunity, Volume 49, 2015, Pages 206-215, ISSN 0889-1591, https://doi.org/10.1016/j.bbi.2015.06.001.

  3. Poidinger (2015): Immunparameter bei remittiert depressiven und gesunden Probanden unter Berücksichtigung der Reaktion auf die Exposition mit psychosozialen Stressoren. Dissertation, n = 71

  4. Raison, Borisov, Woolwine, Massung, Vogt, Miller (2010): Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior. Mol Psychiatry. 2010 May;15(5):535-47. doi: 10.1038/mp.2008.58.

  5. Weinstein, Deuster, Francis, Bonsall, Tracy, Kop (2010): Neurohormonal and inflammatory hyper-responsiveness to acute mental stress in depression, Biological Psychology, Volume 84, Issue 2, 2010, Pages 228-234, ISSN 0301-0511, https://doi.org/10.1016/j.biopsycho.2010.01.016. n = 28

  6. Mende (2018): Diclofenac – Ein Coxib undercover? Pharmazeutische Zeitung 36/2018

  7. Müller: Psychoneuroimmunologische Grundlagen psychischer Erkrankungen, in: Möller, Laux, Kapfhammer (Hrsg.) (2017): Psychiatrie, Psychosomatik, Psychotherapie, Band 1, 5. Auflage, Kapitel 11, S. 291 – 310

  8. Peng, Zhang, Yan, Zhang, Yang, Wang, Song (2020): EPA is More Effective than DHA to Improve Depression-Like Behavior, Glia Cell Dysfunction and Hippcampal Apoptosis Signaling in a Chronic Stress-Induced Rat Model of Depression. Int J Mol Sci. 2020 Mar 5;21(5):E1769. doi: 10.3390/ijms21051769. PMID: 32150824.

  9. Gaab, Rohleder, Heitz, Engert, Schad, Schürmeyer, Ehlert (2005): Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome, Psychoneuroendocrinology, Volume 30, Issue 2, 2005, Pages 188-198, ISSN 0306-4530, https://doi.org/10.1016/j.psyneuen.2004.06.008.

  10. Bechter (2013): Schizophrenie – eine milde Enzephalitis? Fortschr Neurol Psychiatr 2013; 81(5): 250-259. DOI: 10.1055/s-0033-1335253

  11. Dalman, Allebeck, Gunnell, Harrison, Kristensson, Lewis, Lofving, Rasmussen, Wicks, Karlsson (2008): Infections in the CNS During Childhood and the Risk of Subsequent Psychotic Illness: A Cohort Study of More Than One Million Swedish Subjects; American Journal of Psychiatry 2008 165:1, 59-65, https://doi.org/10.1176/appi.ajp.2007.07050740, n = 1,187 Millionen

  12. Eaton, Byrne, Ewald, Mors, Chen, Agerbo, Mortensen (2006): Association of Schizophrenia and Autoimmune Diseases: Linkage of Danish National Registers. American Journal of Psychiatry 2006 163:3, 521-528, n = 7.704 Schizophrenie-Betroffene plus deren Eltern

  13. Benros, Mortensen, Eaton (2012): Autoimmune diseases and infections as risk factors for schizophrenia. Annals of the New York Academy of Sciences, 1262: 56-66. doi:10.1111/j.1749-6632.2012.06638.x

  14. Mishra, Pullum, Thayer, Plummer, Conkright, Morris, O’Hara, Demas, Ashley (2020): Chemical sympathectomy reduces peripheral inflammatory responses to acute and chronic sleep fragmentation. Am J Physiol Regul Integr Comp Physiol. 2020 Mar 4. doi: 10.1152/ajpregu.00358.2019. PMID: 32130024.

Diese Seite wurde am 15.02.2024 zuletzt aktualisiert.